skip to Main Content
skip to Footer

General Insights Hero 1920x480 (4:1)

Video

Latham in Focus: Healthcare & Life Sciences Competition Considerations

July 7, 2025

What antitrust issues do healthcare and life sciences companies need to consider as they plan their next deal?

Latham in Focus: Healthcare & Life Sciences Competition Considerations

In this episode of Latham in Focus, Washington, D.C. partner Mandy Reeves, former Global Chair of Latham’s Band 1 Global Antitrust & Competition Practice, explores the impact of new HSR rules on healthcare and life sciences transactions. Mandy discusses how the new rules offer companies a chance to proactively engage with regulators, and covers what buyers should consider before signing a deal.

In this episode of Latham in Focus, Washington, D.C. partner Mandy Reeves, former Global Chair of Latham’s Band 1 Global Antitrust & Competition Practice, explores the impact of new HSR rules on healthcare and life sciences transactions. Mandy discusses how the new rules offer companies a chance to proactively engage with regulators, and covers what buyers should consider before signing a deal.

Endnotes

Reeves, Amanda P.

Amanda P. Reeves

Washington, D.C.

amanda.reeves@lw.com +1.202.637.2183

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.